Product Category: Pre-made recombinant lentivirus; LV-EF1α-iCre-Puro; LV-EF1A-iCre-Puro; LV-EF1α-iCre-IRES-Puro; EF1A-iCre-Puro Lentivirus;
EF1α-iCre-Puro Lentivirus
Description: Cre recombinase is a type I topoisomerase from bacteriophage P1 that catalyzes the site-specific recombination of DNA between loxP sites. Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP
sites in
cells or experimental animals. By optimizing the mammalian codon usage for
Cre recombinase, Cre expression is improved in the mammalian cells. This codon-improved
Cre (known as iCre) transgene shows lower CpG content from the prokaryotic
coding sequence, thus reducing the chances of epigenetic silencing in mammals.
This
LV-EF1α-iCre-Puro
pre-made lentivirus expresses
iCre recombinase with
co-expression of puromycin selection in an IRES cassette under EF1α
promoter. Ready to use
format.
Titer: > 1x109 TU/mL
Selection Antibiotic: Puromycin
Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection
Size: 2 x 25 µL (Std Pack)
Storage Buffer: PBS
Infection Protocol:
Transfer Vector Map:
* Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm
SignaGen公司是一家专注于开发和生产基因转导工具的企业,服务于生物医学研究领域。借助我们独有的技术平台(美国专利商标局号码为 072308和61135606),SignaGen已经成功开发出三大类 DNA/siRNA转染试剂,经验证我们的产品比市场上主导产品效率更高,细胞毒性更低。更重要的是我们提供一个合理的价位。